Alex Tait / Jelly London
From a promising alternative for the flu shot to hope for a "universal" vaccine, we take a look at how scientists at Johnson & Johnson are exploring novel ideas for preventing and treating the flu.
Yves Ndjadi Lopongo @ Médecins Sans Frontières
The company has committed to donate up to 500,000 doses of an investigational Janssen vaccine regimen to help protect citizens of the Democratic Republic of the Congo—the site of the world's second largest outbreak of the disease.
Seven weeks. 19 students. One incredible experience. We're talking about the inaugural Girls Who Code Summer Immersion Program hosted at the company's Raritan location—and we captured it all on video. Watch as two high schoolers take us behind the scenes.
By the time she was in her 20s, Marisa Troy had endured numerous operations for ulcerative colitis. And when he became a new dad, Frank Garufi's life changed in ways he couldn't have imagined when his son was diagnosed with Crohn's disease. Then they found each other.
It's a common skincare dilemma: You're over the acne stage and wrinkles aren't yet a concern, but you're starting to notice dark spots, fine lines and dull skin. This new line can help address all of it—thanks to the team of millennial scientists behind it.
For Prostate Cancer Awareness Month, we sat down with Margaret Yu, M.D., Vice President, Disease Area Leader, Prostate Cancer, Janssen Research & Development, to learn more about the latest scientific strides being made in the battle against one of the most common cancers in men.

Recent Johnson & Johnson Initiatives in the Spotlight

Learn more about the company’s latest groundbreaking programs, game-changing innovations and global partnerships—all aimed at helping change the trajectory of health for humanity.
This site uses cookies as described in our Cookie Policy. Please click the "Accept" button or continue to use our site if you agree to our use of cookies.
You are now leaving jnj.com. The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.
Continue